Hlin Kvartsberg

Senior clinical chemist, head of the assay development section

Skåne University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Hlin Kvartsberg is a Senior Clinical Chemist and the Head of the Assay Development Section at Sahlgrenska University Hospital in Sweden. His research focuses on the development of novel assays and biomarkers for neurodegenerative diseases, particularly Alzheimer's disease. Recent publications highlight his work on immunogen evaluation, plasma p-tau217 assays, and the analysis of neurofilament light oligomers in cerebrospinal fluid.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Przemysław Radosław Kac

University of Gothenburg

SWEDEN

View details

Sanne Abeln

University of Amsterdam

NETHERLANDS

View details

Jonathan Rohrer

University College London

UNITED KINGDOM

View details

Thomas Karikari

Assistant Professor of Psychiatry

University of Pittsburgh

UNITED STATES

View details

Katharina Waury

Vrije Universiteit Amsterdam

NETHERLANDS

View details

Fernando Gonzalez-Ortiz

University of Gothenburg

SWEDEN

View details

Daniel Oliveira

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hlin Kvartsberg

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Data‐driven evaluation of suitable immunogens for improved antibody selection

Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease

A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease

Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.

Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias.

Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals

Neurogranin in Alzheimer's disease and ageing: A human post-mortem study.

γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing

CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.

CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET

Collaborators (7)

Przemysław Radosław Kac

Sanne Abeln

Jonathan Rohrer

Thomas Karikari

Katharina Waury

Fernando Gonzalez-Ortiz

Daniel Oliveira

Make your next move.